[1]曹志超,陈焕玉,张 宏,等.增强CT、多参数能谱CT及增强MR在肝癌TACE后评估的价值分析[J].介入放射学杂志,2025,34(09):971-976.[doi:10.3969/j.issn.1008-794X.2025.09.011]
　CAO Zhichao,CHEN Huanyu,ZHANG Hong,et al.Application of enhanced CT,energy spectrum CT and enhanced MR in evaluating hepatocellular carcinoma after TACE treatment[J].J Intervent Med,2025,34(09):971-976.[doi:10.3969/j.issn.1008-794X.2025.09.011]
点击复制

增强CT、多参数能谱CT及增强MR在肝癌TACE后评估的价值分析()

PDF下载中关闭

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
34
期数:
2025年09
页码:
971-976
栏目:
临床研究
出版日期:
2025-09-25

文章信息/Info

Title:
Application of enhanced CT,energy spectrum CT and enhanced MR in evaluating hepatocellular carcinoma after TACE treatment
文章编号:
1008-794X(2025)-009-0971-06
作者:
曹志超;  陈焕玉;  张 宏;  杨倩倩;  李伍好;  王亚奇;  贺克武
230061 安徽合肥 合肥市第一人民医院(安徽医科大学第三附属医院)影像中心
Author(s):
CAO Zhichao; CHEN Huanyu; ZHANG Hong; YANG Qianqian; LI Wuhao; WANG Yaqi; HE Kewu.
Imaging Center,Hefei Municipal First People's Hospital(Third Affiliated Hospital of Anhui Medical University),Hefei,Anhui Province 230061,China
关键词:
肝细胞癌;  经导管肝动脉化疗栓塞术;  增强CT;  多参数能谱CT;  增强MRI
分类号:
R735.7
DOI:
10.3969/j.issn.1008-794X.2025.09.011
文献标志码:
B
摘要:
目的 研究常规增强CT(CECT)、多参数能谱CT及CEMR等影像学检查在肝细胞癌(HCC)TACE术后肿瘤评估的价值。方法 回顾性分析在本中心行TACE手术且术后1～3个月行常规CECT扫描、多参数能谱CT后处理和CEMR扫描的66例HCC患者。以DSA结果为金标准,将DSA下检出的复发或残存病灶归为阳性病灶,未见明显复发或残存病灶视为阴性病灶,DSA检出且其他检查方式检出的阳性病灶归为真阳性病灶。使用准确率、灵敏度、特异度、Kappa值等指标比较CECT、多参数能谱CT及CEMR在评估TACE术后阳性/阴性病灶的价值,且用检出数目及准确率评价以上检查在碘油沉积状态及其内真阳性病灶的诊断价值。结果 DSA发现阳性病灶133个,阴性病灶35个; CEMR诊断病灶的准确率最高(准确率为88.70%; 均P<0.05); CEMR和能谱CT诊断阳性病灶的效能最高(灵敏度分别为92.31%和81.95%,两者相比P>0.05),诊断阴性病灶的能力三者差异无统计学意义(均P>0.05); Kappa值提示CEMR诊断TACE术后病灶的能力强于能谱CT(Kappa值分别为0.68和0.56; 均P<0.05)。CECT跟多参数能谱CT评价碘油沉积状态准确率相同(均为91.7%); 三者诊断碘油均匀真阳性病灶无明显差异(P>0.05),诊断碘油不均匀真阳性病灶时以CEMR准确率最高(92.50%,均P<0.05)。结论 CEMR与多参数能谱CT较常规CECT诊断效能更可靠,且CEMR诊断效能最高,但评价碘油沉积状态时多参数能谱CT与CECT是更好的选择。

参考文献/References:

[1] Rumgay H,Ferlay J,de Martel C,et al.Global,regional and national burden of primary liver cancer by subtype[J].Eur J Cancer,2022,161:108-118.
[2]Reig M,Forner A,Rimola J,et al.BCLC strategy for prognosis prediction and treatment recommendation:the 2022 update[J].J Hepatol,2022,76:681-693.
[3]Yang K,Zhang XM,Yang L,et al.Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma[J].World J Gastroenterol,2016,22:4835-4847.
[4]张 浩.TACE术后碘油沉积类型与肝癌预后的相关性分析[D].重庆医科大学:2021.
[5]Borges AP,Antunes C,Caseiro-Alves F.Spectral CT:current liver applications[J].Diagnostics(Basel),2023,13:1673.
[6]Sauerbeck J,Adam G,Meyer M.Spectral CT in oncology[J].Rofo,2023,195:21-29.
[7]王 军,沈加林.能谱CT在肝癌TACE术后评估中的应用[J].介入放射学杂志,2016,25:439-442.
[8]马振中,白卓杰.能谱CT单能与螺旋CT诊断肝硬化合并肝细胞肝癌应用分析[J].医学影像学杂志,2023,33:2128-2131.
[9]Mo A,Lin B,Chen D.Efficacy of sequential TACE on primary hepatocellular carcinoma with microvascular invasion after radical resection:a systematic review and meta-analysis[J].World J Surg Oncol,2023,21:277.
[10]Yang C,Luo YG,Yang HC,et al.Effects of early TACE refractoriness on survival in patients with hepatocellular carcinoma:a real-world study[J].J Hepatocell Carcinoma,2022,9:621-631.
[11]Raoul JL,Forner A,Bolondi L,et al.Updated use of TACE for hepatocellular carcinoma treatment:how and when to use it based on clinical evidence[J].Cancer Treat Rev,2019,72:28-36.
[12]Yue X,Jiang Q,Hu X,et al.Quantitative dual-energy CT for evaluating hepatocellular carcinoma after transarterial chemoembolization[J].Sci Rep,2021,11:11127.
[13]Choi WS,Chang W,Lee M,et al.Spectral CT-based iodized oil quantification to predict tumor response following chemoembolization of hepatocellular carcinoma[J].J Vasc Interv Radiol,2021,32:16-22.
[14]Li J,Xu S,Wang Y,et al.Spectral CT-based nomogram for preoperative prediction of perineural invasion in locally advanced gastric cancer:a prospective study[J].Eur Radiol,2023,33:5172-5183.
[15]王 威,周国锋.影像学检查技术在评估肝癌TACE疗效方面的进展[J].临床放射学杂志,2021,40:1239-1242.
[16]Altmayer S,Armelin LM,Pereira JS,et al.MRI with DWI improves detection of liver metastasis and selection of surgical candidates with pancreatic cancer:a systematic review and meta-analysis[J].Eur Radiol,2024,34:106-114.
(收稿日期:2024-07-23)

相似文献/References:

[1]郭丽萍,张晓玲,王莉娜.经导管肝动脉化疗栓塞联合高强度聚焦超声治疗原发性肝癌的护理[J].介入放射学杂志,2010,(04):328.
　GUO Liping,ZHANG Xiaoling,WANG Lina.The nursing care for patients of hepatocellular carcinoma treated with transcatheter hepatic arterial chemoembolization and high intensive focus ultrasound[J].J Intervent Med,2010,(09):328.
[2]沈海洋,杨光,刘瑞宝,等.肝右叶前、后段原发性肝癌动脉化疗栓塞术后近期疗效比较[J].介入放射学杂志,2010,(05):382.
　SHEN Haiyang,YANG Guang,LIU Ruibao,et al.Short－term effects of TACE for primary hepatocellular carcinoma of the right hepatic lobe：a comparison between the lesions in anterior segments and the lesions in posterior segments[J].J Intervent Med,2010,(09):382.
[3]池嘉昌,沈加林,许建荣,等.全肝CT灌注成像在原发性肝癌TACE术后局部病灶活性评估中的临床应用[J].介入放射学杂志,2010,(07):540.
　CHI Jiachang,SHEN Jialin,XU Jianrong,et al.Clinical application of whole－liver perfusion－enhanced CT imaging in evaluating the activity of residual hepatocellular carcinoma after TACE[J].J Intervent Med,2010,(09):540.
[4]翁志成,杨维竹,江娜,等.CT引导下１２５I放射性粒子植入治疗肝癌门静脉癌栓的疗效评价[J].介入放射学杂志,2010,(07):535.
　WENG Zhicheng,YANG Weizhu,JIANG Na,et al.Evaluation of CT－guided１２５I seed implantation combined with transcatheter arterial chemoem－bolization in treating portal vein tumor thrombus associated with hepatocellular carcinoma[J].J Intervent Med,2010,(09):535.
[5]王悍 王精兵 张贵祥 王麟川.肝细胞癌动脉化疗栓塞术后并发脑梗死一例[J].介入放射学杂志,2005,(04):442.
　WANG Han WANG Jing-bing ZHANG Gui-xiang WANG Lin-chuan.Cerebral infarction aften transaterial shemoembolization for hepatocellular carcinoma a cage report[J].J Intervent Med,2005,(09):442.
[6]张绪敬,程佩芳,董光,等.原发性肝癌经导管化疗、栓塞前后血中凝血酶原变化的研究[J].介入放射学杂志,1992,(01):33.
[7]吴纪瑞,杨永岩,杨熙章,等.丝裂霉素C微囊肝动脉化疗栓塞术治疗中晚期肝癌[J].介入放射学杂志,1992,(01):41.
[8]欧阳墉,马和平,张学军,等.肝细胞癌的鉴别诊断——附10例分析[J].介入放射学杂志,1996,(01):40.
[9]周斌,李征然,钱结胜,等.原发性肝癌肝移植后肿瘤复发的化疗栓塞治疗[J].介入放射学杂志,2009,(03):185.
　ZHOU Bin,LI Zhengran,QIAN Jiesheng,et al.Chemoembolization for recurrent hepatocellular carcinoma after liver transplantation[J].J Intervent Med,2009,(09):185.
[10]黄渊全,贾中芝,冯耀良,等.CT灌注成像在肝癌TACE术后疗效评价中的应用价值[J].介入放射学杂志,2009,(06):437.
　HUANG Yuan-quan,JIA Zhong-zhi,FENG Yao-liang,et al.Clinical application of CT perfusion imaging in estimating the efficacy of transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma[J].J Intervent Med,2009,(09):437.
[11]顾 杰,马 雷,张正宇,等.TACE联合双艾对比TACE联合阿帕替尼治疗CNLC Ⅲ期肝细胞癌的有效性及安全性[J].介入放射学杂志,2025,34(07):756.[doi:10.3969/j.issn.1008-794X.2025.07.013]
　GU Jie,MA Lei,ZHANG Zhengyu,et al.TACE plus apatinib and camrelizumab versus TACE plus apatinib for CNLC Stage Ⅲ hepatocellular carcinoma:comparison of the clinical efficacy and safety[J].J Intervent Med,2025,34(09):756.[doi:10.3969/j.issn.1008-794X.2025.07.013]

备注/Memo

备注/Memo:
通信作者: 贺克武 E-mail:hekewu@ahmu.edu.cn
更新日期/Last Update: 2025-09-25